Anti-Butyryl-Histone H3 (Lys23) Mouse mAb
PTM-307
ApplicationsWestern Blot, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
Overview
- SupplierPTM BIO
- Product NameAnti-Butyryl-Histone H3 (Lys23) Mouse mAb
- Delivery Days Customer5
- Antibody SpecificityAnti-Butyryl-Histone H3 (Lys23) Mouse mAb detects histone H3 only when it is butyrylated at Lys23.
- ApplicationsWestern Blot, ImmunoHistoChemistry Paraffin
- Applications SupplierWB, IHC-P
- Category SupplierAntibody
- CertificationResearch Use Only
- ClonalityMonoclonal
- ConjugateUnconjugated
- HostMouse
- IsotypeIgG
- Protein IDP68431
- Protein NameHistone H3.1
- Scientific DescriptionHistones are subject to a variety of enzyme catalyzed modifications, including acetylation, methylation, Phosphorylatedrylation, ubiquitylation, etc. Butyrylation of lysine is a newly identified reversible modification controlling chromosome structure and gene transcription. Lysine butyrylation is highly conserved in eukaryotic cells from worm to human. The unique structure and genomic localization of histone lysine butyrylation suggest that it is mechanistically and functionally different from histone lysine acetylation. Specifically, in both human somatic and rabbit male germ cell genomes, histone butyrylation marks either active promoters or potential enhancers. Butyrylation of histone H3 at Lys18 may play a vital role in the epigenetic modulation, including chromatin remodeling and DNA transcriptional regulation.
- Shelf life instructionStable for 12 months from date of receipt/reconstitution.
- ReactivityHuman, Mouse, Rat
- Reactivity SupplierHuman, Mouse, Rat
- Reactivity Supplier NoteProtein G and immunogen affinity purified
- Storage InstructionStore at -20°C. Avoid freeze/thaw cycles.
- UNSPSC12352203
References
- Kezhi Yan, et al. 'Deficient histone H3 propionylation by BRPF1-KAT6 complexes in neurodevelopmental disorders and cancer' Science Advances (2020)Read more
- Aditya Bhattacharya, et al. 'Butyrylation Meets Adipogenesis-Probed by a p300-Catalyzed Acylation-Specific Small Molecule Inhibitor: Implication in Anti-obesity Therapy' JOURNAL OF MEDICINAL CHEMISTRY (2022)Read more
- Jo Chanhee, et al. 'Histone acylation marks respond to metabolic perturbations and enable cellular adaptation' EXPERIMENTAL AND MOLECULAR MEDICINE (2020)Read more